Sunday, 28 April 2024 04:36

Cheap, decades-old drug could be secret to longevity: scientists

Rate this item
(0 votes)

 

A cheap drug used to treat diabetes may help you live a longer, healthier life, scientists believe.

Metformin, which helps people lower their blood sugar and treats Type 2 diabetes, could also protect against cancer, cognitive decline and heart disease.

This is due to its anti-inflammatory effects, NPR reported. It costs less than a dollar a day under some insurance plans.

Scientists are testing their hypothesis with a study called the TAME Trial to see whether metformin can slow down aging and prevent disease in older healthy adults. The six-year trial aims to enroll 3,000 people between the ages of 65 and 79.

Connecticut’s West Hartford Mayor Shari Cantor and her attorney husband, Michael Cantor, both take metformin and credit the drug with improving their lifestyle. They are both in their mid-60s.

Michael started taking the drug 10 years ago to help him manage his weight and his blood sugar, and Shari started taking it over the pandemic because she heard it could prevent infections.

“I tell all my friends about it. We all want to live a little longer, high-quality life if we can,” Michael told NPR.

A researcher on aging also weighed in.

“I don’t know if metformin increases lifespan in people, but the evidence that exists suggests that it very well might,” said Steven Austad, a senior scientific adviser at the American Federation for Aging Research who studies the biology of aging.

Studies suggest that metformin lowers the risk of blood, urologic and gastrointestinal cancers.

“That was a bit of a shock,” Austad said.

He also referred to a British study that found that the drug lowered dementia risk in people who took the med for Type 2 diabetes. People taking metformin also had a lower risk of dying from a cardiovascular issue.

Austad and other researchers pushed for a clinical trial because most metformin aging benefits have been observational.

“A bunch of us went to the FDA to ask them to approve a trial for metformin. If you could help prevent multiple problems at the same time like we think metformin may do, then that’s almost the ultimate in preventative medicine,” Austad said.

The Cantors say they haven’t experienced any negative side effects, although some metformin users have reported trouble building new muscle and a vitamin B deficiency.

 

New York Post

January 13, 2025

Fuel prices in Nigeria likely to surge as Brent crude rises above $81

Fuel prices in Nigeria are expected to climb further as Brent crude prices surged above…
January 11, 2025

Ohanaeze Ndigbo gets new President-General

John Azuta-Mbata, a former senator, has been elected as the new president-general of Ohanaeze Ndigbo,…
January 12, 2025

Why some animals appear to mourn their dead

Grief has long thought to be a human trait, but other animals – from killer…
January 04, 2025

Shy man cuts off 4 fingers instead of telling boss he wanted to quit his…

A 32-year-old Indian man admitted to cutting off four fingers on his left hand to…
January 13, 2025

Bandits attack Zamfara mosque, kidnap dozens of worshippers

Armed assailants launched an attack on a mosque in Birnin Yaro village, Zamfara state, kidnapping…
January 13, 2025

What to know after Day 1054 of Russia-Ukraine war

RUSSIAN PERSPECTIVE Ukraine won’t reclaim all Russian-held territories – Trump adviser It is not possible…
December 25, 2024

Stem cell therapy to correct heart failure in children could 'transform lives'

Renowned visionary English physician William Harvey wrote in 1651 about how our blood contains all…
January 08, 2025

NFF appoints new Super Eagles head coach

The Nigeria Football Federation (NFF) has appointed Éric Sékou Chelle as the new Head Coach…

NEWSSCROLL TEAM: 'Sina Kawonise: Publisher/Editor-in-Chief; Prof Wale Are Olaitan: Editorial Consultant; Femi Kawonise: Head, Production & Administration; Afolabi Ajibola: IT Manager;
Contact Us: [email protected] Tel/WhatsApp: +234 811 395 4049

Copyright © 2015 - 2025 NewsScroll. All rights reserved.